CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs (NCT04538313) | CAR-T (Shanghai) Cell Biotechnology Co., Ltd. | 2020-08-26 |
Track CAR-T (Shanghai) Cell Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.